The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

Objective

The aim of this study was to examine the magnitude of poor persistence in treatment among patients with schizophrenia and to identify associated factors.

Methods

All eligible patients (N=216) seen at the University College Hospital in Ibadan, Nigeria, over a five-year period were retrospectively followed up until the time of their last visit. Time to first default was examined by Kaplan-Meier survival analyses. A log-rank test was used to compare survival times for different variables. The contribution of the variables that affected time to default was examined by Cox regression analysis.

Results

Only 24% of the sample remained in treatment at the one-year follow-up. Persistence as measured by mean±SE time to all-cause treatment default was 17.80±1.44 weeks. Of several variables examined, including whether patients were taking first- or second-generation antipsychotics, none were found to predict persistence.

Conclusions

Persistence in treatment of patients with a first episode of schizophrenia was low.